ClinicalTrials.Veeva

Menu
R

Re-Cognition Health | Plymouth, United Kingdom

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

BI 409306
JNJ-64042056
Lanabecestat
LY3314814

Parent organization

This site is a part of Re-Cognition Health

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 4 total trials

A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease (Reτain)

The purpose of this study is to assess the effect of JNJ-64042056 on cognitive decline, as measured by Preclinical Alzheimer's disease Cognitive Comp...

Enrolling
Preclinical Alzheimer's Disease
Drug: JNJ-64042056
Drug: Placebo

Trial sponsors

Boehringer Ingelheim logo
AstraZeneca logo
Janssen (J&J Innovative Medicine) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems